Stock Market News

BoFA says Novo Nordisk may miss Q1 expectations as Wegovy, Ozempic sales lag

Mar 28, 2025 - 13:52
 0
BoFA says Novo Nordisk may miss Q1 expectations as Wegovy, Ozempic sales lag
Read More

Tags:

Previous Article

U.S. stock futures extend losses after key PCE inflation; Lululemon disappoints

Next Article

American worker confidence just hit a record low and is even worse than it was d...

Related Posts

Zscaler 'growth drivers show signs of improvement': BofA

Mar 7, 2025  0

Earnings surprise, RBI easing could lift pressured Indi...

Mar 26, 2025  0

Canada stocks lower at close of trade; S&P/TSX Composite down 0.54%

Canada stocks lower at close of trade; S&P/TSX Composit...

Mar 11, 2025  0